[1]. Sabnis RW. Novel Heteroaromatic Carboxamides as Plasma Kallikrein Inhibitors for Treating Diabetic Complications, Ocular Diseases, and Edema-Associated Diseases. ACS Med Chem Lett. 2021 Oct 21;12(11):1637-1638.